Cargando…
COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke
BACKGROUND: Anticoagulation is an important means to prevent from acute ischemic stroke but is associated with a significant risk of severe hemorrhages. Previous studies have shown that blood coagulation factor XII (FXII)-deficient mice are protected from pathological thrombus formation during cereb...
Autores principales: | Kraft, Peter, Schwarz, Tobias, Pochet, Lionel, Stoll, Guido, Kleinschnitz, Christoph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831840/ https://www.ncbi.nlm.nih.gov/pubmed/20298537 http://dx.doi.org/10.1186/2040-7378-2-5 |
Ejemplares similares
-
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
por: Kleinschnitz, Christoph, et al.
Publicado: (2006) -
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2010) -
The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders—A Systematic Review
por: Göbel, Kerstin, et al.
Publicado: (2018) -
Matemáticas para COU
por: Pérez Carreras, Pedro
Publicado: (1988) -
Targeting coagulation factor XII as a novel therapeutic option in brain trauma
por: Hopp, Sarah, et al.
Publicado: (2016)